| Cancer statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 9.9K |
| Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Cancer Research | 2014 | 3.8K |
| Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification | Journal of Clinical Oncology | 2014 | 2.4K |
| International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma | Lancet Oncology, The | 2014 | 2.3K |
| Cancer treatment and survivorship statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 2.1K |
| Colorectal cancer statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 2.1K |
| The treatment-naive microbiome in new-onset Crohn's disease | Cell Host and Microbe | 2014 | 1.8K |
| Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab | Journal of Clinical Oncology | 2014 | 1.7K |
| Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy | Clinical Cancer Research | 2014 | 1.7K |
| Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis | Journal of the National Cancer Institute | 2014 | 1.6K |
| Breast cancer statistics, 2013 | Ca-A Cancer Journal for Clinicians | 2014 | 1.5K |
| Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial | Lancet Oncology, The | 2014 | 1.5K |
| Liquid biopsies: genotyping circulating tumor DNA | Journal of Clinical Oncology | 2014 | 1.4K |
| Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial | Lancet Oncology, The | 2014 | 1.4K |
| Childhood and adolescent cancer statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 1.4K |
| Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival | Cancer Cell | 2014 | 1.3K |
| Revisiting STAT3 signalling in cancer: new and unexpected biological functions | Nature Reviews Cancer | 2014 | 1.3K |
| Drug resistance in cancer: an overview | Cancers | 2014 | 1.3K |
| AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer | Cancer Discovery | 2014 | 1.2K |
| Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study | Lancet Oncology, The | 2014 | 1.2K |
| Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma | Cancer Cell | 2014 | 1.2K |
| A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma | Cancer Cell | 2014 | 1.2K |
| FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial | Lancet Oncology, The | 2014 | 1.2K |
| The epidemiology of glioma in adults: a "state of the science" review | Neuro-Oncology | 2014 | 1K |
| CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011 | Neuro-Oncology | 2014 | 1K |
